Swedbank AB Sells 11,386 Shares of The Clorox Company $CLX

Posted by Lindsey Winhoffer on May 10th, 2026

Swedbank AB cut its stake in The Clorox Company (NYSE:CLX – Free Report) by 15.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,504 shares of the company’s stock after selling 11,386 shares during the quarter. Swedbank AB’s holdings in Clorox were worth $6,504,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Clorox by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares during the last quarter. Woodline Partners LP lifted its position in Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after buying an additional 7,465 shares during the last quarter. Baird Financial Group Inc. lifted its position in Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after buying an additional 424 shares during the last quarter. Jump Financial LLC lifted its position in Clorox by 173.5% in the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after buying an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia lifted its position in shares of Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after purchasing an additional 3,352 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Down 0.1%

NYSE:CLX opened at $92.04 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a fifty day simple moving average of $106.03 and a 200-day simple moving average of $108.04. The company has a market cap of $11.13 billion, a price-to-earnings ratio of 14.94, a price-to-earnings-growth ratio of 0.48 and a beta of 0.59. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $138.23.

Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the previous year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts anticipate that The Clorox Company will post 5.63 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were issued a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 5.4%. The ex-dividend date was Wednesday, April 22nd. Clorox’s payout ratio is presently 80.52%.

More Clorox News

Here are the key news stories impacting Clorox this week:

Positive Sentiment: Unusual options activity showed strong bullish speculation, with traders buying 14,071 CLX call options on Friday, far above the typical daily volume. This may signal expectations for a rebound.
Positive Sentiment: Several articles highlighted Clorox as a high-yield dividend stock, noting its roughly 5.7% yield and its potential to become a Dividend King in 2027 if it continues raising payouts.
Positive Sentiment: A director reportedly bought about $429,100 worth of Clorox shares, which investors often view as a sign of insider confidence.
Neutral Sentiment: Long-term performance commentary emphasized Clorox’s consistency as a consumer staples company, with steady dividends and resilience over the past decade, but without a clear new catalyst for near-term earnings. If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff
Negative Sentiment: Pomerantz LLP said it is investigating claims on behalf of Clorox investors, adding legal uncertainty that could weigh on the stock. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company – CLX
Negative Sentiment: Commentary noted that Clorox has fallen to an 11-year low, reflecting weaker investor confidence despite its dividend yield. Contrarian Take: This High-Yield Dividend Stock Is a Buy in May Despite Falling to an 11-Year Low

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CLX. Jefferies Financial Group decreased their target price on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Wells Fargo & Company decreased their target price on Clorox from $110.00 to $100.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Wall Street Zen upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 target price on shares of Clorox in a research report on Friday, May 1st. Finally, Rothschild & Co Redburn set a $117.00 target price on Clorox in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $104.00.

Read Our Latest Report on CLX

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.63% of the stock is owned by insiders.

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.